AI & Machine Learning

The sheer scale of potential chemical compounds, estimated at ten to the sixtieth power, has long stood as an insurmountable barrier for pharmaceutical researchers attempting to identify viable therapeutic candidates. Traditionally, identifying a single molecule capable of binding to a specific

The clinical landscape of hepatobiliary surgery has undergone a profound transformation as medical teams increasingly rely on high-resolution imaging to evaluate donor organs before any surgical intervention begins. For decades, the decision to accept or reject a donor liver rested on subjective

The biological complexity of cancer requires a precision that traditional treatments often lack, creating a desperate need for solutions that can adapt to the unique genetic profile of every individual patient. While generic chemotherapy and radiation have long been the standard of care, the

Developing therapeutic interventions for the central nervous system has long been regarded as one of the most arduous challenges in the pharmaceutical industry due to the physiological complexity of the human brain. Traditionally, central nervous system drugs have faced a higher attrition rate

Ivan Kairatov is a seasoned Biopharma expert whose career has been defined by the pursuit of technological innovation in research and development. With a deep-seated understanding of how automated systems can transform biological monitoring, he offers a unique perspective on the digital evolution

The ongoing escalation of antimicrobial resistance has effectively pushed modern medicine toward a precipice where common infections could once again become untreatable without a fundamental shift in drug discovery. This looming crisis is particularly evident in the treatment of Neisseria